(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):659-63. doi: 10.1016/j.pnpbp.2011.02.019. Epub 2011 Mar 2.

Authors

Michael Maes, Brian Leonard, Alberto Fernandez, Marta Kubera, Gabriel Nowak, Rob Veerhuis, Ann Gardner, Piaynuj Ruckoanich, Michel Geffard, Carlo Altamura, Piotr Galecki, Michael Berk

PMID: 21376099
DOI: 10.1016/j.pnpbp.2011.02.019

No abstract available

Publication types

Editorial

MeSH terms

Anti-Inflammatory Agents / therapeutic use
Antidepressive Agents / therapeutic use*
Antioxidants / therapeutic use*
Depression / drug therapy*
Depression / immunology
Depression / metabolism
Drug Discovery
Humans
Inflammation / drug therapy*
Inflammation / physiopathology
Molecular Targeted Therapy
Neuroimmunomodulation / drug effects
Neuroimmunomodulation / physiology
Protein Kinase Inhibitors / therapeutic use*

Substances

Anti-Inflammatory Agents
Antidepressive Agents
Antioxidants
Protein Kinase Inhibitors